Insiders · Profile

Horn Howard

Chief Financial Officer at Ultragenyx Pharmaceutical · CFO at Vir Biotechnology. Filing since 1 Jun 2020. CIK 0001786335

Company
Date
Role
Action
Shares
Amount
Of holding
3 Aug 2026
Chief Financial Officer
Sold on a plan
4,696
$117.02K
4.6%
1 Jul 2026
Chief Financial Officer
Sold on a plan
4,698
$155.64K
4.4%
1 Jun 2026
Chief Financial Officer
Sold on a plan
4,653
$110.60K
4.2%
1 May 2026
Chief Financial Officer
Sold on a plan
4,683
$116.61K
4.1%
1 Apr 2026
Chief Financial Officer
Sold on a plan
4,683
$98.20K
5.5%
3 Mar 2026
Chief Financial Officer
Sold on a plan
1,635
$36.62K
1.9%
2 Mar 2026
Chief Financial Officer
Sold on a plan
8,409
$190.91K
8.8%
2 Feb 2026
Chief Financial Officer
Sold on a plan
3,061
$72.12K
3.3%
2 Jan 2026
Chief Financial Officer
Sold on a plan
3,150
$71.95K
3.3%
10 Dec 2025
Chief Financial Officer
Sold on a plan
3,081
$112.09K
3.1%
13 Oct 2025
Chief Financial Officer
Sold at will
7,942
$250.25K
7.5%
6 Mar 2025
Chief Financial Officer
Sold at will
1,785
$72.11K
1.7%
10 Oct 2024
Chief Financial Officer
Sold at will
7,465
$393.85K
7.5%
23 Feb 2023
CFO
Sold, plan not stated
2,248
$58.39K
1.0%
17 Feb 2023
CFO
Sold, plan not stated
2,424
$61.30K
1.0%
17 Feb 2022
CFO
Sold, plan not stated
2,393
$76.41K
1.2%
13 Jul 2020
CFO
Sold, plan not stated
30,000
$1.50M
14.4%
2 Jul 2020
CFO
Sold, plan not stated
10,000
$400.00K
4.6%
1 Jul 2020
CFO
Sold, plan not stated
10,000
$378.40K
4.4%
25 Jun 2020
CFO
Sold, plan not stated
30,000
$1.50M
11.6%
19 Jun 2020
CFO
Sold, plan not stated
10,000
$400.00K
3.7%
1 Jun 2020
CFO
Sold, plan not stated
10,000
$351.04K
3.6%
22 decisions on file.